S100β and serotonin: A possible astrocytic-neuronal link to neuropathology of Alzheimer's disease

Progress in Brain Research

Volumn 94, Issue C, 1992, Pages 459-473

  Azmitia, Efrain C ^a   Griffin, W Sue T ^b   Marshak, Daniel R ^c   Van Eldik, Linda J ^d   Whitaker Azmitia, Patricia M ^e  

^a NEW YORK UNIVERSITY   (United States)

^b ARKANSAS CHILDREN S RESEARCH INSTITUTE   (United States)

^c Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN; SEROTONIN RECEPTOR;

ALZHEIMER DISEASE; ASTROCYTE; CONFERENCE PAPER; HUMAN; HUMAN TISSUE; NERVE CELL; NERVE DEGENERATION; NEUROPATHOLOGY; PROTEIN ANALYSIS;

EID: 0027049818     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)61773-2     Document Type: Article

References (98)

1. Allore, R., O'Hanlon, D., Price, R., Neilson, K., Willard, H.F., Cox, D.R., Marks, A., Dunn, R.J., Gene encoding the β subunit of S100 protein is on chromosome 21: implications for Down syndrome. Science 239 (1988), 1311–1313.
2. Allore, R.J., Friend, W.C., O'Hanlon, D., Neilson, K.M., Baumal, R., Dunn, R.J., Marks, A., Cloning and expression of the human S100β gene. J. Biol. Chem. 265 (1990), 15537–15543.
3. Azmitia, E.C., The serotonin-producing neurons of the midbrain median and dorsal raphe nuclei. Iversen, L.L., Iversen, S.D., Snyder, S.H., (eds.) Handbook of Psychopharmacology, 9, 1978, Plenum, New York, 233–314.
4. Azmitia, E.C., Gannon, P.J., Anatomy of the serotonergic system in the primate and subprimate brain. Myoclonus – Adv. Neurol. 43 (1986), 407–468 S. Fahn, C.D. Marsden and M. Van Woert (Eds.).
5. Azmitia, E.C., Whitaker-Azmitia, P.M., Target cell stimulation of serotonergic neurons in primary dissociated tissue culture. Neuroscience 20 (1987), 47–63.
6. E.C. Azmitia, F.C. Zhou (1986) Chemically induced homotypic collateral sprouting of hippocampal serotonergic afferents. In: G.M. Gilad, A. Gorio and G.W. Kreutzberg (Eds.), Process of Recovery from Neural Trauma – Exp. Brain Res. (Suppl 13), pp. 129–141.
7. Azmitia, E.C., Whitaker-Azmitia, P.M., Bartus, R., Use of tissue culture models to study neuronal regulatory trophic and toxic factors in the aged brain. Neurobiol. Aging 9 (1988), 743–758.
8. Azmitia, E.C., Dolan, K., Whitaker-Azmitia, P.M., S100β but not NGF, EGF, insulin or calmodulin is a CNS serotonergic growth factor. Brain Res. 516 (1990), 354–356.
9. Azmitia, E.C., Lama, P., Segal, M., Whitaker-Azmitia, P.M., Murphy, R.B., Zhou, F.C., Effects of hippocampal supernatant extract on the development of serotonergic neurons in dissociated microcultures. Int. J. Dev. Neurosci. 9 (1991), 251–258.
10. Barger, S.W., Van Eldik, L.J., S100β stimulates calcium fluxes in glial and neuronal cells. J. Biol. Chem. 267 (1992), 9689–9694.
11. Bar-Peled, O., Gross-Isseroff, R., Ben-Hur, H., Hoskins, I., Groner, Y., Biegon, A., Fetal human brain exhibits a prenatal peak in the density of serotonin 5-HT1A receptors. Neurosci. Lett. 127 (1991), 173–176.
12. Baudier, J., Glasser, N., Gerard, D., Ions binding to S100 proteins. I. Calcium-and zinc-binding properties of bovine brain S100αα, S100a (αβ), and S100b (ββ) proteins: Zn2+ regulates Ca2+ binding on S100b protein. J. Biol. Chem. 261 (1986), 8192–8203.
13. Bhattacharyya, A., Oppenheim, R.W., Prevette, D., Moore, B.W., Brackenbury, R., Ratner, N., S100 is present in developing chicken neurons and Schwann cells and promotes motor neuron survival in vivo. J. Neurobiol. 23 (1992), 451–466.
14. Blue, M.E., Molliver, M.E., Serotonin influences barrel formation in developing somatosensory cortex of the rat. Soc. Neurosci. Abstr., 15, 1989, 419.
15. Boyes, B.E., Kim, S.U., Kim, L.V., Sung, S.C., Imunohistochemical co-localization of S100β and the glial fibrillary acidic protein in rat brain. Neuroscience 17 (1986), 857–865.
16. Cicero, T.J., Ferrendelli, J.A., Suntzeff, V., Moore, B.W., Regional changes in CNS levels of the S100 and 14–3-2 proteins during development and aging of the mouse. J. Neurochem. 19 (1972), 2119–2125.
17. Cotman, C.W., Lynch, G.S., Reactive synaptogenesis in the adult nervous system: the effects of partial deafferentation on new synapse formation. Barondes, S., (eds.) Neuronal Recognition, 1976, Plenum, New York, 69–108.
18. Cross, A.J., Serotonin in Alzheimer-type dementia. Ann. N.Y. Acad. Sci., 600, 1990, 405.
19. Cross, A.J., Cros, T.J., Ferrier, I.N., Johnson, J.A., Bloom, S.R., Corsellis, J.A.N., Serotonin receptor changes in dementia of Alzheimer type. J. Neurochem., 43, 1984, 1574.
20. D'Amato, R.J., Zweig, R.M., Whitehouse, P.J., Wenk, J.C., Singer, H.S., Mayeux, R., Price, D.L., Snyder, S.H., Aminergic systems in Alzheimer's disease and Parkinson's disease. Ann. Neurol., 22, 1987, 229.
21. Dannies, P.S., Levine, L., The role of sulfhydryl groups in serological properties of bovine brain S100 proteins. J. Biol. Chem. 246 (1971), 6284–6287.
22. Daugherty, J.A., Haring, J.H., Effects of neonatal serotonin depletion upon development of rat somatosensory cortex. Soc. Neurosci. Abstr., 15, 1989, 1050.
23. Daval, G., Verge, D., Becerril, A., Gozlan, H., Spaminato, U., Hamon, M., Transient expression of 5-HT1A receptor binding sites in some areas of the rat CNS during postnatal development. Int. J. Dev. Neurosci., 5, 1987, 171.
24. Donato, R., S-100 proteins. Cell Calcium 7 (1986), 123–145.
25. Duncan, A.M.V., Higgins, J., Dunn, R.J., Allore, R., Marks, A., Refined sublocalization of the human gene encoding the β subunit of the S100 protein (S100β) and confirmation of a subtle t(9;21) translocation using in situ hybridization. Cytogenet. Cell. Genet. 50 (1989), 234–235.
26. Dunn, R., Landry, C., O'Hanlon, D., Dunn, J., Allore, R., Brown, I., Marks, A., Reduction in S100 protein β subunit mRNA in C6 rat glioma cells following treatment with anti-microtubular drugs. J. Biol. Chem. 262 (1987), 3562–3566.
27. Fan, K., S100 protein synthesis in cultured glioma cell is G1-phase of cell cycle dependent. Brain Res. 237 (1982), 498–503.
28. Francis, P.T., Palmer, A.M., Sims, N.R., Bowen, D.M., Davison, A.M., Esiri, M.M., Neary, D., Snowden, J.S., Wilcock, G.K., Neurochemical studies of early onset Alzheimer's disease: possible influence on treatment. N. Engl. J. Med., 313, 1985, 7.
29. Goldgaber, D., Lerman, M.L., McBride, O.W., Saffiotti, U., Gajdusek, D.C., Characterization and chromosomal localization of cDNA encoding brain amyloid of Alzheimer's disease. Science 235 (1987), 877–880.
30. Griffin, W.S.T., Stanley, L.C., Johnson, J.S., Woody, R.C., Gliosis in diseases with neurodegeneration and immune suppression. Soc. Neurosci. Abstr., 15, 1989, 302.
31. Griffin, W.S.T., Stanley, L.C., Ling, C., White, L., MacLeod, V., Perrot, L.T., White, C.L., Araos, C., Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 86 (1989), 7611–7615.
32. Griffin, W.S.T., Stanley, L.C., Mrak, R.C., Perrot, L.J., S100β is elevated in brain cells of AIDS patients. Soc. Neurosci. Abstr., 17, 1991, 1273.
33. Halgren, E., Varon, S., Serotonin turnover in cultured raphe nuclei from newborn rats: in vitro development and drug effects. Brain Res. 48 (1972), 438–442.
34. Hertz, L., Is Alzheimer's disease an anterograde degeneration, originating in the brain-stem, and disrupting metabolic and function interactions between neurons and glial cells?. Brain Res. Rev., 14, 1989, 335.
35. Higashida, H., Sano, M., Kato, K., Forskolin induction of S-100 protein in glioma and hybrid cells. J. Cell. Physiol. 122 (1985), 39–44.
36. Isobe, T., Okuyama, T., The amino acid sequence of S100 protein (PAPI-b protein) and its relation to the Ca2+ binding proteins. Eur. J. Biochem. 89 (1978), 379–388.
37. Kitt, C.A., Walker, L.C., Molliver, M.E., Price, D.L., Serotonergic neurites in senile plaques in cingulum cortex of aged non-human primates. Synapse 3 (1989), 12–18.
38. Kligman, D., Isolation of a protein from bovine brain which promotes neurite extension from chick embryo cerebral cortex neurons in defined medium. Brain Res. 250 (1982), 93–100.
39. Kligman, D., Hsieh, L.J., Neurite extension factor induces rapid morphological differentiation of mouse neuroblastoma cells in defined medium. Dev. Brain Res. 33 (1987), 296–300.
40. Kligman, D., Marshak, D.R., Purification and characterization of a neurite extension factor from bovine brain. Proc. Natl. Acad. Sci. U.S.A. 82 (1985), 7136–7139.
41. Kosik, K.S., Joachim, C.L., Selkoe, D.L., Microtubule-associated protein tau (τ) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 83 (1986), 4044–4048.
42. Kuwano, R., Usui, H., Maeda, T., Fukui, T., Yamanari, N., Ohtsuka, E., Ikehara, M., Takahashi, Y., Molecular cloning and complete nucleotide sequence of cDNA to mRNA for S100 protein of rat brain. Nucleic Acids Res. 12 (1984), 7455–7465.
43. Labourdette, G., Marks, A., Synthesis of S-100 protein in monolayer cultures of rat glial cells. Eur. J. Biochem. 58 (1975), 73–79.
44. Lauder, J., Hormonal and humoral influences of brain development. Psychoneuroendocrinology 8 (1983), 121–155.
45. Lee, V.M., Balin, B.J., Otvos, L. Jr., Trojanowski, J.Q., A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 251 (1991), 675–678.
46. Lidov, H.G.W., Molliver, M.E., An immunohistochemical study of serotonin neuron development in the rat: ascending pathways and terminal fields. Brain Res. Bull. 8 (1982), 389–430.
47. Magistretti, P.J., Morrison, J.J., Shoemaker, W.J., Sapin, V., Bloom, F.E., Vasoactive intestinal peptide induces glycogenolysis in mouse cortical slices: a possible regulatory mechanism for the local control of energy metabolism. Proc. Natl. Acad. Sci. U.S.A., 78, 1981, 6535.
48. Mann, D.M.A., The neuropathology of Alzheimer's disease: a review with pathogenetic, etiological and therapeutic considerations. Arch. Aging Dev., 31, 1985, 213.
49. Manthrope, M., Pettmann, B., Varon, S., Modulation of astroglial output of neuronotrophic and neurite promoting factors. Norenberg, M., Hertz, L., Schousboe, A., (eds.) The Biochemical Pathology of Astrocytes, 1988, Alan R. Liss, New York, 41–57.
50. Marks, A., Petsche, D., O'Hanlon, D., Kwong, P.C., Stead, R., Dunn, R., Baumal, R., Liao, S.-K., S100 protein expression in human melanoma cells: comparison of levels of expression among different cell lines and individual cells in different phases of the cell cycle. Exp. Cell Res. 187 (1990), 59–64.
51. Marshak, D.R., S100β as a neurotrophic factor. Prog. Brain Res. 86 (1990), 169–181.
52. Marshak, D.R., Lukas, T.J., Watterson, D.M., Drugprotein interactions: binding of chlorpromazine to calmodulin, calmodulin fragments, and related calcium binding proteins. Biochemistry 24 (1985), 151–157.
53. Marshak, D.R., Pesce, S.A., Stanley, L.C., Griffin, W.S.T., Increased S100β neurotrophic activity in Alzheimer disease temporal lobe. Neurobiol. Aging 13 (1992), 1–7.
54. Middlemiss, D.N., Palmer, A.M., Edel, N., Bainen, D.M., Binding of novel serotonin agonist 8-hydroxy-2-(di-n-proprylamino) tetralin in normal and Alzheimer brain. J. Neurochem., 46, 1984, 993.
55. Moore, B., A soluble protein characteristic of the nervous system. Biochem. Biophys. Res. Commun. 19 (1965), 739–744.
56. Muller, R., Bravo, R., Burckhardt, J., Curren, T., Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature 312 (1984), 716–720.
57. O'Callaghan, J.P., Miller, D.B., Jensen, K.F., Schmidt, C.J., Serotonin depletions are not predictive of neurotoxicity: evidence from increases in glial fibrillary acidic protein induced by methylenedioxymethamphetamine (MDMA) and 5,7-dihydroxytryptamine (5,7-DHT). Soc. Neurosci. Abstr., 16, 1990, 256.
58. Palacios, J.M., Waeber, C., Hoyer, D., Mengod, G., Distribution of serotonin receptors. Ann. N.Y. Acad. Sci. 600 (1990), 36–51.
59. Palmer, A.M., Francis, P.T., Benton, J.S., Sims, N.R., Mann, D.M., Neary, D., Snowden, J.M., Bowen, D.M., Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. J. Neurochem., 48, 1987, 8.
60. W. Park, E.C. Azmitia (1991) Role of 5–HT drugs and nimodipine on Ca2+ transport into synaptosomes. Third IBRO World Congress of Neuroscience, IBRO (Abstr.): 285.
61. Probst, A., Ulrich, J., Heitz, P.U., Senile dementia of Alzheimer type: astroglial reaction to extracellular neurofibrillary tangles in the hippocampus. An immunocytochemical and electron-microscopic study. Acta Neuropathol. (Berl.) 57 (1982), 75–79.
62. Qin-Wei, Y., Prevette, D., Oppenheim, R.W., Van Eldik, L.J., Brain extract and glial-derived trophic agents prevent deafferentation-induced motoneuron death in the chick embryo. Soc. Neurosci. Abstr., 17, 1991, 1123.
63. Reier, P.J., Houle, J.D., Tessler, A., Jakeman, L., Astrogliosis and regeneration: new perspective to an old hypothesis. Norenberg, M., Hertz, L., Schousboe, A., (eds.) The Biochemical Pathology of Astrocytes, 1988, Alan R. Liss, New York, 107–122.
64. Reisert, I., Han, V., Hartwig, S., Ahnert-Hilger, G., Pilgrim, C., Rapid maturation of synaptic functions of prenatal serotonergic neurons in short-term cultures: absence of sex differences and hormone effects. Neuroscience 32 (1989), 133–139.
65. Rumble, B., Retallack, R., Hilbich, C., Simms, G., Multhaup, G., Martins, R., Hockey, A., Montgomery, P., Beyreuther, K., Masters, C.L., Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer disease. N. Engl. J. Med. 320 (1989), 1446–1452.
66. Schroer, J.A., Haring, J.H., Hippocampal 5-HT innervation density influences the expression of GFAP and S-100 detected by immunocytochemistry. Soc. Neurosci. Abstr., 17, 1991, 934.
67. Selinfreund, R.H., Barger, S.W., Welsh, M.J., Van Eldik, L.J., Antisense inhibition of glial S100β production results in alterations in cell morphology, cytoskeletal organization, and cell proliferation. J. Cell Biol. 111 (1990), 2021–2028.
68. Selinfreund, R.H., Barger, S.W., Pledger, W.J., Van Eldik, L.J., The neurotrophic protein S100β stimulates glial cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 88 (1991), 3554–3558.
69. Shashoua, V.E., Hesse, G.W., Moore, B.W., Proteins of the brain extracellular fluid: evidence for release of S100 protein. J. Neurochem. 42 (1984), 1536–1541.
70. George-Hyslop, P.H.St., Tanzi, R.E., Polinsky, R.J., Hines, J.L., Nee, L., Watkins, P.C., Myers, R.H., Feldman, R.G., Pollen, D., Drachman, D., Growden, J., Bruni, A., Foncin, J.-F., Salmon, D., Frommelt, P., Amaduci, L., Sorbi, S., Piacentini, S., Stewart, G.D., Hobbs, W.J., Conneally, P.M., Gusella, J.F., The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 235 (1987), 885–890.
71. Suzuki, F., Kato, K., Kato, T., Ogasawara, N., S-100 protein in clonal astroglioma cells is released by adrenocorticotrophic hormone and corticotropin-like intermediate-lobe peptide. J. Neurochem., 49, 1987, 1557 1563.
72. Tanzi, R.E., Gusella, J.F., Watkins, P.C., Bruns, G.A.P., George-Hyslop, P.St., Van Keuren, M.D., Patterson, D., Pagan, S., Kurnit, D.M., Neve, R.L., Amyloid β protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer locus. Science 235 (1987), 880–884.
73. Tork, I., Anatomy of the serotonergic system. Ann. N.Y. Acad. Sci. 600 (1990), 9–35.
74. Van Eldik, L.J., Zimmer, D.B., Secretion of S-100 from rat C6 glioma cells. Brain Res. 436 (1987), 362–370.
75. Van Eldik, L.J., Zimmer, D.B., Mechanisms of action of the S100 family of calcium modulated proteins. Gerday, C.H., Gilles, R., (eds.) Calcium and Calcium Binding Proteins, 1988, Springer, Berlin, 114–127.
76. Van Eldik, L.J., Zendegui, J.G., Marshak, D.R., Watterson, D.M., Calcium binding proteins and the molecular basis of calcium action. Int. Rev. Cytol. 77 (1982), 1–61.
77. Van Eldik, L.J., Staecker, J.L., Winningham-Major, F., Synthesis and expression of a gene coding for the calcium-modulated protein S100β and designed for cassettebased, site-directed mutagenesis. J. Biol. Chem. 263 (1988), 7830–7837.
78. Van Eldik, L.J., Christie-Pope, B., Bolin, L.M., Shooter, E.M., Whetsell, W.O., Neurotrophic activity of S100β in cultures of dorsal root ganglia from embryonic chick and fetal rat. Brain Res. 542 (1991), 280–285.
79. Van Hartsveldt, C., Moore, B.W., Hartman, B.K., Transient midline raphe glial structure in the developing rat. J. Comp. Neurol. 253 (1986), 175–184.
80. Wallace, J.A., Lauder, J.M., Development of the serotonergic system in the rat embryo: an immunocytochemical study. Brain Res. Bull. 10 (1983), 459–479.
81. Whitaker, P.M., Vint, C.K., Morin, R., 3HImipramine labels sites on brain astroglial cells not related to serotonin uptake. J. Neurochem., 41, 1983, 1319.
82. Whitaker-Azmitia, P.M., Role of serotonin and other neurotransmitter receptors in brain development: the basis for developmental pharmacology. Pharmacol. Rev. 43 (1991), 553–561.
83. Whitaker-Azmitia, P.M., Azmitia, E.C., 3H-5-Hydroxytryptamine binding to brain astroglial cells: differences between intact and homogenized preparations and mature and immature cultures. J. Neurochem. 46 (1986), 1186–1191.
84. Whitaker-Azmitia, P.M., Azmitia, E.C., Stimulation of astroglial serotonin receptors produces culture media which regulate growth of serotonergic neurons. Brain Res. 497 (1989), 80–86.
85. Whitaker-Azmitia, P.M., Lauder, J.M., Shemmer, A., Azmitia, E.C., Postnatal changes in 5-HT-1 receptors following prenatal alterations in serotonin levels: further evidence for functional fetal 5-HT-1 receptors. Dev. Brain Res. 33 (1987), 285–295.
86. Whitaker-Azmitia, P.M., Murphy, R., Azmitia, E.C., Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology. Brain Res. 528 (1990), 155–158.
87. Winningham-Major, F., Whetsell, W.O., Van Eldik, L.J., Recombinant neurotrophic factor promotes survival and stimulates neurite outgrowth in nervous system cultures. J. Cell Biol., 107, 1988, 729a.
88. Winningham-Major, F., Staecker, J.L., Barger, S.W., Coats, S., Van Eldik, L.J., Neurite extension and neuronal survival activities of recombinant S100β proteins that differ in the content and position of cysteine residues. J. Cell Biol. 109 (1989), 3063–3071.
89. Wisniewski, K.E., Wisniewski, H.M., Wen, G.Y., Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down syndrome. Ann. Neurol. 17 (1985), 278–282.
90. Woody, R.C., Stanley, L.C., Roberts, G.W., Griffin, W.S.T., β-Amyloid immunoreactivity in hippocampus from fetal, neonatal, infant, adolescent, and adult Down's syndrome. Ann. Neurol., 26, 1989, 485.
91. Yamamoto, M., Steinbusch, H.W.M., Jessell, T.M., Differential properties of identified serotonin neurons in dissociated cultures of neurons in dissociated cultures of embryonic rat brain stem. J. Cell Biol. 91 (1981), 142–152.
92. Yamamoto, T., Hirano, A., Nucleus raphe dorsalis in Alzheimer disease: neurofibrillary tangles and loss of large neurones. Ann. Neurol. 17 (1985), 573–577.
93. Yankner, B.A., Duffy, L.K., Kirschner, D.A., Neurotrophic and neurotoxic effects of amyloid β-protein: reversal by tachykinin neuropeptides. Science 250 (1990), 279–282.
94. Yocca, F., Maayani, S., 5-HT receptors linked to adenyl cyclase in mammalian brain. Ann. N.Y. Acad. Sci. 600 (1990), 212–222.
95. Zhou, F.C., Azmitia, E.C., Laminin facilitates and guides fiber growth of transplanted neurons in adult brain. J. Chem. Neuroanat. 1 (1988), 133–146.
96. Zhou, F.C., Auerbach, S.B., Azmitia, E.C., Denervation of serotonergic fibers in the hippocampus induced a trophic factor which enhances the maturation of transplanted serotonergic neurons but not norepinephrine neurons. J. Neurosci. Res. 17 (1987), 235–246.
97. Zimmer, D.B., Van Eldik, L.J., Analysis of the calcium-modulated proteins, S100 and calmodulin, and their target proteins during C6 glioma cell differentiation. J. Cell Biol. 108 (1989), 141–151.
98. Zuckerman, J.E., Herschman, H.R., Levine, L., Appearance of a brain specific antigen (the S-100 protein) during human foetal development. J. Neurochem. 17 (1970), 247–251.